Ferrell B R, Griffith H
City of Hope National Medical Center, Duarte, California 91010-0269.
J Pain Symptom Manage. 1994 May;9(4):221-34. doi: 10.1016/0885-3924(94)90099-x.
The clinical problem of unrelieved pain has received much attention over the previous decade with a major focus on cancer pain and acute postoperative pain. Organizations such as the World Health Organization (WHO), the National Cancer Institute, the American Pain Society (APS), and others have addressed the previously neglected areas of pain assessment, pharmacologic treatment, and the knowledge and attitudes of health-care providers. Health-policy issues related to pain, including areas of cost, access to care, regulatory perspectives, and ethical and legal issues, have likewise been neglected. To explore the costs associated with pain, the following framework has been developed through the Agency for Health Care Policy and Research (AHCPR) pain panel. This 13-point framework is an attempt to isolate specific cost issues, identify what is known in these areas, and address implications for future research. A brief synopsis of these 13 areas of cost analysis is provided including comments regarding work in progress by the panel and directions for future health-policy research related to pain management.
在过去十年中，疼痛未得到缓解这一临床问题受到了广泛关注，主要集中在癌症疼痛和急性术后疼痛方面。世界卫生组织（WHO）、美国国立癌症研究所、美国疼痛协会（APS）等组织已着手解决此前被忽视的疼痛评估、药物治疗以及医疗保健提供者的知识和态度等领域的问题。与疼痛相关的卫生政策问题，包括成本、医疗服务可及性、监管视角以及伦理和法律问题等领域，同样被忽视了。为了探究与疼痛相关的成本，医疗保健政策与研究机构（AHCPR）疼痛专题小组制定了以下框架。这个包含13点的框架旨在分离特定的成本问题，确定这些领域已知的情况，并探讨对未来研究的影响。以下提供了这13个成本分析领域的简要概述，包括对专题小组正在进行的工作的评论以及与疼痛管理相关的未来卫生政策研究方向。
